PHARMA NEWS

PHARMA NEWS :- Pharmatimes

Guesswork to guidance February 6, 2026
What content do HCPs value most for their patient care?
John Pinching
Connect more February 5, 2026
Redefining the future of customer relationships in biopharma
John Pinching
Patient-centric oncology trials February 5, 2026
Data-driven, patient-first: using insights in striving to transform cancer care
John Pinching
Thomas Farrell February 4, 2026
NanoSyrinx has appointed Thomas Farrell as CEO and Director
John Pinching
Ahmed Moussa February 4, 2026
Ahmed Moussa is the new Sanofi Country Lead for UK & Ireland
John Pinching
Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay February 3, 2026
The company will initially develop a vaccine to tackle colorectal and pancreatic cancers
Esme Needham
IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease February 3, 2026
Perovial is the first ever hyaluronic acid injectable treatment to be licensed for acute Peyronie’s disease
Esme Needham
En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation February 2, 2026
The US sees around 476,000 new Lyme cases every year
Esme Needham
ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children February 2, 2026
Anaphylaxis is the most serious type of allergic reaction and occurs more commonly in boys
Esme Needham
CERo reports encouraging early data from phase 1 trial of CER‑1236 January 29, 2026
CER‑T therapy shows initial safety signals and prompts protocol expansion
John Pinching

Guesswork to guidance
What content do HCPs value most for their patient care?
Connect more
Redefining the future of customer relationships in biopharma
Patient-centric oncology trials
Data-driven, patient-first: using insights in striving to transform cancer care
Thomas Farrell
NanoSyrinx has appointed Thomas Farrell as CEO and Director
Ahmed Moussa
Ahmed Moussa is the new Sanofi Country Lead for UK & Ireland
Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
The company will initially develop a vaccine to tackle colorectal and pancreatic cancers
IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
Perovial is the first ever hyaluronic acid injectable treatment to be licensed for acute Peyronie’s disease
En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
The US sees around 476,000 new Lyme cases every year
ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
Anaphylaxis is the most serious type of allergic reaction and occurs more commonly in boys
CERo reports encouraging early data from phase 1 trial of CER‑1236
CER‑T therapy shows initial safety signals and prompts protocol expansion

GMP and Quality

Non-conformances in Pharmaceutical Laboratories

Pharma VedMay 8, 2024

Pharmaceutical quality control laboratories are the guardians of public health. Through meticulous testing of raw materials, in-process materials, and finished products, they ensure the safety and efficacy of medications. However, nonconformances can arise...